As Health Reform Advanced, Device Firms Spent Heavily On Blue Dogs
This article was originally published in The Gray Sheet
Executive Summary
Device firms have spent heavily on members of Congress seeking to slow the progress and limit the scope of health care reform legislation, according to lobbying contribution records maintained by the clerk of the House and secretary of the Senate